References
- Nerup J, Mandrup-Poulsen T, Mølvig J, Helqvist S, Wogensen L, Egeberg J. Mechanisms of pancreatic β-cell destruction in type 1 diabetes. Diabetes Care 1988; 11: 16–23, Suppl 1
- Bendtzen K. Immune hormones (cytokines): pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 1989; 22: 177–189
- Bendtzen K, Mandrup-Poulsen T, Nerup J, Dinarello C A, Svenson M, Nielsen JH. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
- Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C A, Svenson M, Nielsen JH. Affinity-purified human interleukin 1 is cytotoxic to islets of Langerhans. Diabetologia 1986; 29: 63–67
- Zawalich W S, Diaz VA. Interleukin 1 inhibits insulin secretion from isolated perifused rat islets. Diabetes 1986; 35: 1119–1123
- Sandier S, Andersson A, Hellerström C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
- Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen J H, Dinarello CA. Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Ada Pathol Microhiol Immunol Scand [C] 1987; 95: 55–63
- Comens P G, Wolf B A, Unanue E R, Lacy P E, McDaniel ML. Interleukin I is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 1987; 36: 963–970
- Mandrup-Poulsen T, Bendtzen K, Dinarello C, Nerup J. Human tumor necrosis factor potentiates human interleukin-1 mediated rat pancreatic β-cell cytotoxicity. J Immunol 1987; 139: 4077–4082
- Eizirik DL. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol 1988; 119: 321–325
- Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of inter-feron-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37: 133–136
- Eizirik D L, Strandell E, Bendtzen K, Sandier S. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1. Diabetes 1988; 37: 916–919
- Sandier S, Bendtzen K, Borg L AH, Eizirik D L, Strandell E, Welsh N. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1β indicate a perturbation in the mitochondrial. function. Endocrinology 1989; 124: 1492–1501
- Eizirik D L, Sandier S, Hallberg A, Bendtzen K, Sener A, Malaisse WJ. Differential sensitivity to β-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1β. Endocrinology 1989; 125: 752–759
- Sandier S, Bendtzen K, Eizirik D L, Strandell E, Welsh M, Welsh N. Metabolism and β-cell function of rat pancreatic islets exposed to human interleukin-1β in the presence of a high glucose concentration. Immunol Lett 1990; 26: 245–252
- Wolf B A, Hughes J A, Florholmen J, Turk J, McDaniel ML. Interleukin-1 inhibits glucose-induced Ca2+ uptake by islets of Langerhans. FEBS Lett 1989; 248: 35–38
- Borg L AH, Eizirik DL. Short-term exposure of rat pancreatic islets to human interleukin-1β increases cellular uptake of calcium. Immunol Lett 1990; 26: 253–258
- Eizirik D L, Welsh M, Sirandell E, Welsh N, Sandier S. Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 1990; 127: 2290–2297
- Andersson A. Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia 1978; 14: 397–404
- Svenson M, Bendtzen K. Interleukin 1 inhibitor in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line. Scand J Immunol 1988; 27: 593–599
- Krebs H A, Henseleit K. Untersuchungen über die Harnstoffbil-dung in Tierkprper. Hoppe Seylers Z Physiol Chem 1932; 210: 33–36
- Halban P A, Wolheim C B, Blondel B, Renold AE. Long-term exposure of isolated pancreatic islets to mannoheptulose: evidence for insulin degradation in the β-cell. Biochem Pharmacol 1980; 29: 2625–2633
- Eizirik D L, Sandier S, Welsh N, Hellerström C. Preferential reduction of insulin production in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinology 1988; 122: 1242–1249
- Heding LG. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260–266
- Andersson A, Sandier S. Viability tests of cryopreserved endocrine pancreatic cells. Criobiology 1983; 20: 161–168
- Thomas P. Hybridization of denaturated RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 1980; 77: 5201–5205
- White B A, Bancroft FC. Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol Chem 1982; 251: 8569–8572
- Chan S J, Noyes B E, Agarwal K L, Steincr DF. Construction and selection of recombinant plasmids containing full-length complementary DNAs corresponding to rats insulins I and II. Proc Nail Acad Sci USA 1979; 76: 5036–5040
- Hughes J H, Colcoa J R, Easom R A, Turk J, McDaniel ML. Interleukin-1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 1990; 86: 856–863
- Eizirik D L, Bendtzen K, Sandier S. Short exposure of rat pancreatic islets to interleukin-1β induces a sustained but reversible impairment in β-cell function. This effect is influenced by protease activation, gene transcription and protein synthesis. Endocrinology 1991, In press
- Hammonds P, Beggs M, Beresford G, Espinal J, Clarke J, Mertz RJ. Insulin-secreting β-cells possess specific receptors for interleukin-1β. FEES Lett 1990; 261: 97–100
- Fagarasan M O, Bishop J F, Rinaudo M S, Axelrod J. Interleukin 1 induces early protein phosphorylation and requires only a short exposure for late induced secretion of β-endorphin in a mouse pituitary cell line. Proc Natl Acad Sci USA 1990; 87: 2555–2559
- Welsh M, Nielsen D A, MacKrell A J, Steiner DF. Control of insulin, gene expression in pancreatic β-cells and in an insulin-producing cell line, RIN-5F cells. J Biol Chem 1985; 260: 13590–13594
- Welsh N. A role for polyamines in glucose-stimulated insulin-gene expression. Biochem J 1990; 271: 393–397
- Welsh M. Glucose regulation of insulin gene expression. Diabet Metab 1989; 15: 367–371
- Eizirik D L, Sandier S, Sener A, Malaisse WJ. Defective catabolism of D-glucose and L-glutamine in mouse pancreatic islets maintained in culture after streptozotocin exposure. Endocrinology 1988; 123: 1001–1007
- Welsh N, Svensson C, Welsh M. Content of adenine nucleotide translocator mRNA in insulin-producing cells of different functional states. Diabetes 1989; 38: 1377–1380